ArticleThe EMBO journal2021
ALK ligand ALKAL2 potentiates MYCN-driven neuroblastoma in the absence of ALK mutation.
Marcus Borenäs et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this paperpooled itcites it
ArticleThe EMBO journal2021
Marcus Borenäs et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.